POSC288 Evidence Requirements in the Regulatory and Reimbursement Processes of Digital Therapeutics: Insights from the US, EU4 and UK

Abstract

Authors

A. Morga A. Chettiath A. Saxena

Full Text Cite This Article
Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×